286 related articles for article (PubMed ID: 16624629)
1. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.
McGillicuddy FC; O'Toole D; Hickey JA; Gallagher WM; Dawson KA; Keenan AK
Vascul Pharmacol; 2006 Jun; 44(6):469-75. PubMed ID: 16624629
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
[TBL] [Abstract][Full Text] [Related]
3. [Effects of fluvastatin on the activation of p38 mitogen-activated protein kinase in glomerular mesangial cells under high concentration of glucose].
Wang LH; Wu GL; Zhang LX; Huang XD; Li S
Yao Xue Xue Bao; 2009 Feb; 44(2):121-5. PubMed ID: 19408679
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1.
Naito T; Masaki T; Nikolic-Paterson DJ; Tanji C; Yorioka N; Kohno N
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F278-87. PubMed ID: 14583433
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin upregulates the α 1C subunit of CaV1.2 channel expression in vascular smooth muscle cells via RhoA and ERK/p38 MAPK pathways.
Ouyang QF; Han Y; Lin ZH; Xie H; Xu CS; Xie LD
Dis Markers; 2014; 2014():237067. PubMed ID: 25614710
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
Lien SC; Usami S; Chien S; Chiu JJ
Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases.
Chen G; Khalil N
Respir Res; 2006 Jan; 7(1):2. PubMed ID: 16390551
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells.
Ito T; Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Shimada K
Cardiovasc Drugs Ther; 2002 Mar; 16(2):121-6. PubMed ID: 12090904
[TBL] [Abstract][Full Text] [Related]
10. DLPC decreases TGF-beta1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells.
Cao Q; Mak KM; Lieber CS
Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1051-61. PubMed ID: 12381518
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.
Desai P; Helkin A; Odugbesi A; Stein J; Bruch D; Lawler J; Maier KG; Gahtan V
J Surg Res; 2017 Apr; 210():1-7. PubMed ID: 28457315
[TBL] [Abstract][Full Text] [Related]
12. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
[TBL] [Abstract][Full Text] [Related]
13. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
Suzuki H; Uchida K; Nitta K; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
[TBL] [Abstract][Full Text] [Related]
14. Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts.
Nakagawa T; Lan HY; Glushakova O; Zhu HJ; Kang DH; Schreiner GF; Böttinger EP; Johnson RJ; Sautin YY
J Am Soc Nephrol; 2005 Apr; 16(4):899-904. PubMed ID: 15716330
[TBL] [Abstract][Full Text] [Related]
15. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway.
Oak MH; Chataigneau M; Keravis T; Chataigneau T; Beretz A; Andriantsitohaina R; Stoclet JC; Chang SJ; Schini-Kerth VB
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1001-7. PubMed ID: 12676803
[TBL] [Abstract][Full Text] [Related]
16. p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes.
Takahashi Y; Maki T; Liang AC; Itoh K; Lok J; Osumi N; Arai K
Brain Res; 2014 Dec; 1593():1-8. PubMed ID: 25451097
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 stimulates HO-1 via the p38 mitogen-activated protein kinase in A549 pulmonary epithelial cells.
Ning W; Song R; Li C; Park E; Mohsenin A; Choi AM; Choi ME
Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1094-102. PubMed ID: 12376363
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway.
Hashimoto S; Gon Y; Takeshita I; Matsumoto K; Maruoka S; Horie T
Am J Respir Crit Care Med; 2001 Jan; 163(1):152-7. PubMed ID: 11208641
[TBL] [Abstract][Full Text] [Related]
20. Regulation of peroxisome proliferator-activated receptor-γ by angiotensin II via transforming growth factor-β1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells.
Subramanian V; Golledge J; Heywood EB; Bruemmer D; Daugherty A
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):397-405. PubMed ID: 22095985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
